UNSPSC 41202023: Equine encephalomyelitis virus serological reagents

In this classification, Equine encephalomyelitis virus serological reagents are devices used in test to identify specific Equine encephalomyelitis virus antibodies in serum. US FDA regulates Equine encephalomyelitis virus serological reagents under 21 CFR 866.3240 and under FDA product code GQD.

UNSPSC 41202023 Equine encephalomyelitis virus serological reagents is a Commodity code, but the recent solicitation activity under this code bears no substantive connection to the code's stated scope. The handful of posted opportunities under 41202023 address HIV, syphilis, and drug-testing reagents and laboratory services — not equine encephalomyelitis diagnostics. The mismatch suggests either a catalog tagging error at the posting source or that this code is being used as a catch-all for unrelated clinical laboratory reagent procurement and does not reflect genuine activity in equine encephalomyelitis serology.

The limited relevant activity that does appear clusters around state health departments and county public health and criminal justice agencies. The Illinois Department of Public Health has posted multiple solicitations for Abbott HIV and syphilis reagents (May 2026 emergency procurement and August 2026 change order notice), while the City of Austin and Collin County have each posted for HIV test kits and general laboratory services. Collin County also solicited for drug-testing supplies and offender specimen collection services. Geographic reach is sparse — Illinois, Texas (Austin and Collin County), and Georgia (Gwinnett County) — with no established pattern of repeat buying or sustained procurement activity under the nominal code. No representative equine encephalomyelitis serology solicitations appear in the record, and the code shows little decision-relevant activity for a vendor focused on that product line.